Drug Resistance, Multiple, Bacterial
Conditions
Brief summary
Multicenter retrospective study conducted in the intensive care units of Tourcoing, Roubaix, and Lille hospitals. Patients hospitalized in the ICU with EBLSE bacteremia within 24 hours before or during their stay in the ICU will be selected from microbiology laboratory data. Patient demographics and clinical data will be collected from the medical record. Microbiological results will be collected from the laboratory data.
Detailed description
INCLUSION CRITERIA - Patients admitted to the ICU with EBLSE bacteremia within 24 hours before or during their stay in the ICU. PRIMARY ENDPOINT \- The primary endpoint is 30-day mortality.
Interventions
None listed
Sponsors
Tourcoing Hospital
Study design
Observational model
COHORT
Time perspective
RETROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Patients admitted to the ICU with EBLSE bacteremia within 24 hours before or during their stay in the ICU.
Exclusion criteria
* Patient who is a minor, protected adult, or who refuses to participate.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| The primary endpoint is all-cause 30-day mortality. | 30-day mortality | all-cause mortality. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Adequacy of initial antibiotic therapy to french recommendations | adequate within 30 days | Antibiotic prescriptions will be considered adequate if all of the following criteria meet the recommendations: molecule, dose, according to the recommendations provided by the French Society of Infectious Diseases. The recommendations for prescribing antibiotics are similar to those proposed by international guidelines. |
Countries
France
Contacts
Primary ContactMEYBECK Angès, MD
Outcome results
None listed